Dr Kenneth Allen Fischer, MD | |
1419 Westport Landing Pl, Suite 101, Manhattan, KS 66502-2906 | |
(785) 776-7500 | |
(785) 770-8558 |
Full Name | Dr Kenneth Allen Fischer |
---|---|
Gender | Male |
Speciality | Plastic Surgery |
Location | 1419 Westport Landing Pl, Manhattan, Kansas |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134131402 | NPI | - | NPPES |
100396860A | Medicaid | KS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208200000X | Plastic Surgery | 04-28013 (Kansas) | Primary |
2086S0105X | Surgery - Surgery Of The Hand | 04-28013 (Kansas) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Dr Kenneth Allen Fischer, MD 1419 Westport Landing Pl, Suite 101, Manhattan, KS 66502-2906 Ph: (785) 776-7500 | Dr Kenneth Allen Fischer, MD 1419 Westport Landing Pl, Suite 101, Manhattan, KS 66502-2906 Ph: (785) 776-7500 |
News Archive
OSI Systems, Inc., a vertically-integrated provider of specialized electronic products for critical applications in the Security and Healthcare industries, today announced that its Healthcare division, Spacelabs Healthcare, launched XPREZZONTM, a patient monitoring solution that delivers innovative technology and design to shape the new age of care for clinicians and patients alike.
Health ingredients Europe 2010, the global event for the nutraceutical, functional health and natural ingredients industry exceeded all expectations. The decision to take the show to Spain brought high rewards, altering the landscape of the show and bringing exhibitors from over 40 countries and registered visitors from over 100 countries.
The U.S. Food and Drug Administration today launched a Web page for consumers with information on how to dispose of certain drugs, including several high-potency opioids and other selected controlled substances.
The Wellcome Trust has awarded a £1.6 million Translation Award to a research team led by the University of Lincoln to develop more effective radiotherapy treatment for thousands of cancer sufferers by providing unique monitoring and imaging for patients receiving proton therapy.
› Verified 5 days ago